# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Craig-Hallum analyst Jason Kreyer maintains Cardlytics (NASDAQ:CDLX) with a Buy and lowers the price target from $18 to $12.
Needham analyst Kyle Peterson maintains Cardlytics (NASDAQ:CDLX) with a Buy and lowers the price target from $17 to $12.
Billings of $115.0 million - $126.0 million, Adjusted EBITDA ($3.0) million - $1.0 million